Compounded Semaglutide and Tirzepatide Are Ending: What to Do Next

If your compounded semaglutide or tirzepatide program stops, it is not because your pharmacy did anything unusual. The federal permission those programs relied on ended (for semaglutide, in April and May 2025), and FDA has since proposed keeping both drugs off the bulks list that outsourcing facilities work from. That proposal is not final yet. There are three lawful ways forward, and one route to avoid.

Why the program ended

Compounding semaglutide and tirzepatide at scale was lawful mainly because both drugs sat on FDA's shortage list. That condition is gone: FDA determined the tirzepatide shortage resolved on December 19, 2024, and set the end of its enforcement discretion for compounded semaglutide at April 22, 2025 for state-licensed pharmacies and May 22, 2025 for outsourcing facilities.^[1] On April 30, 2026 the agency proposed that all three molecules (semaglutide, tirzepatide, liraglutide) stay off the bulks list that outsourcing facilities depend on, concluding there was no clinical need for them.^[2] Comments closed on July 30, 2026. As of October 17, 2026, FDA has published no final determination.^[4] Our full explanation of the two compounding routes covers what each one requires.

The practical effect is that a program built on cheap compounded supply has no rule left to stand on, and the ones still advertising are running out of room.

Route 1 — the brand-name drug, priced direct

The manufacturers now sell several of these drugs directly for cash, an option that did not exist when the compounding market formed. That is the closest replacement for what you were taking, because it is the same molecule in an FDA-approved presentation, and it is the only route where what is in the vial has been reviewed.

It usually costs more than compounded did. Compare what the direct-pay programs and the telehealth sellers charge on our live price tracker rather than on any seller's own headline, which is frequently a first-month rate.

Some telehealth clinics now support that route rather than replacing it. HuHealth runs a $59-a-month care plan for people buying Wegovy or Zepbound directly from the maker.

Route 2 — insurance, if you have a path to it

Coverage for weight management remains patchy and plan-specific, and it is the route people abandon fastest because the first answer is often no. It is still worth one call, because the difference between covered and cash is larger than any discount a seller will offer you. Check what your state and plan cover in our insurance coverage register.

Medicare is the exception that changed in 2026. Through the Medicare GLP-1 Bridge, eligible Part D enrollees pay a $50 copay for certain GLP-1s between July 1, 2026 and December 31, 2027.^[5] The covered drugs are Foundayo, Wegovy (injection or tablet) and the Zepbound KwikPen. Eligibility depends on BMI and specific conditions, and people with type 2 diabetes are excluded.^[6]

Route 3 — a documented individual need, still compounded

Compounding did not become illegal. A 503A pharmacy may still compound for a specific patient whose need the approved product cannot meet: a documented reaction to something in the approved formulation, or a strength the commercial pens are not made in. What ended was compounding at scale as a business model. If a prescriber believes you have such a need, that route is open and it is narrow.^[1]

The route to avoid

Sellers offering "research peptides", vials sold as not-for-human-use, or semaglutide with no prescription at all are not a fourth option. They sit outside the pharmacy system entirely, which means no pharmacy license to check, no prescriber, and nothing to verify about what is in the vial. FDA has warned about counterfeit and unapproved GLP-1 products reaching patients through these channels.^[3]

FDA has taken action against sellers whose vials carried the labels “for research purposes” and “not for human consumption”. That wording does legal work; it does not describe a grade of product. It has also said it is aware of counterfeit Ozempic reaching American buyers. Its own guidance for anyone buying online comes down to one instruction: use a state-licensed pharmacy.^[3]

• No prescription required is not a convenience. It means no clinician is accountable for your dose.
• "Research use only" on the label is the seller telling you, in writing, that it is not for you to inject.
• No named pharmacy means there is no license to look up and no one to complain to.

What to ask before you move

1. Is this the approved product or a compounded one? If compounded, on what basis, now that the shortage has ended?
2. Which pharmacy dispenses it, and is it named anywhere I can check?
3. What does the monthly figure include (medication, the consult, shipping), and what is billed separately?
4. What is the billing cycle? A price quoted per month is sometimes charged every four weeks, which is thirteen payments a year rather than twelve.

One more question belongs on that list: how do I get out if I switch again? Moving between routes is common right now, and the exit terms vary more than the prices do. All of these sellers say you can cancel anytime; what differs is what you get back.

• Nothing renews. CoraDoc sells only prepaid programs with no auto-renewal, though there is no refund once the medication is prescribed. Invyncible sells one vial at a time with no subscription, and holds payment as an authorization that is released if the physician does not approve.
• Partial money back on a prepaid plan. MyFastRx refunds a canceled prepaid plan minus the months you received, repriced at the shorter plan’s rate, and refunds an order in full if it is canceled before it reaches the pharmacy. Jyra Health refunds the medication cost before shipment and offers a pause of up to three months.
• A short window, then nothing. FeelGood refunds only in the first three days before any service or on medical disqualification. Clume Health refunds within the first 72 hours before any service, and the month you cancel in is not refunded.
• Renews until you stop it. Medivive renews monthly until canceled and does not refund shipped medication. Medical Health Institute bills program fees until you cancel and gives refund terms at the point of purchase. AVArx lets you pause, skip or cancel from the dashboard, and EverFit Medical charges nothing if you are not approved but keeps payments once a prescription is issued.